HighTide Therapeutics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-291.16	-381.79	-939.31	-190.24	-221.15
Depreciation & Amortization	6.21	5.9	1.83	1.27	1.59
Loss (Gain) From Sale of Assets	0.08	0.21	-	-	0
Loss (Gain) From Sale of Investments	0.43	6.11	522.16	-23.24	93.66
Stock-Based Compensation	56.02	96.93	93.49	25.62	7.3
Other Operating Activities	-11.73	-29.77	-23.31	-10.58	14.72
Change in Accounts Payable	16.1	20.97	8.81	15.61	-0.81
Change in Unearned Revenue	-	-	-0.33	-3.89	3.42
Change in Other Net Operating Assets	-10.69	-17.03	-19.96	13.07	10.72
Operating Cash Flow	-234.74	-298.47	-356.62	-172.38	-90.55
Capital Expenditures	-4.29	-4.29	-0.8	-0.18	-1.75
Sale of Property, Plant & Equipment	-0.09	-	-	-	0
Investment in Securities	-2.91	-78.19	293.18	-423.92	-
Other Investing Activities	22.19	27.81	22.98	8.44	3.33
Investing Cash Flow	14.9	-54.66	315.36	-415.66	1.59
Short-Term Debt Issued	-	61.83	5	15	10
Total Debt Issued	105	61.83	5	15	10
Short-Term Debt Repaid	-	-8.44	-9.65	-13.85	-187.52
Long-Term Debt Repaid	-	-2.86	-0.98	-0.99	-1.27
Total Debt Repaid	-27.57	-11.3	-10.63	-14.84	-188.79
Net Debt Issued (Repaid)	77.43	50.53	-5.63	0.16	-178.79
Issuance of Common Stock	-	-	252.9	-	-
Other Financing Activities	43.08	-1.53	113.84	-1.26	-18.41
Financing Cash Flow	120.51	49	361.1	46.03	493.98
Foreign Exchange Rate Adjustments	-0.36	6.67	15.32	49.76	-6.99
Net Cash Flow	-99.69	-297.46	335.17	-492.24	398.04
Free Cash Flow	-239.03	-302.75	-357.42	-172.56	-92.29
Free Cash Flow Per Share	-0.53	-0.67	-1.38	-0.68	-2.19
Cash Interest Paid	3.09	1.53	0.4	0.3	0.31
Cash Income Tax Paid	-	0.53	0.11	0.02	0.01
Levered Free Cash Flow	-165.1	-177	-194.44	-86.71	-
Unlevered Free Cash Flow	-163.46	-176.04	-194.19	-86.45	-
Change in Working Capital	5.41	3.94	-11.48	24.79	13.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.